http://www.zibb.com/all/theme/cq/ICON+Plc Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Wed, 25 Nov 2009 17:50:30 GMTWed, 25 Nov 2009 17:50:30 GMT608831http://www.zibb.com/all/theme/cq/ICON+Plc http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.quotelinks.com/companies/iclr.htmlStock quotes, news and charts for ICON plc Quotes Simple Charts Stock News MSN Investor Thomson Investors Short Interest Yahoo Finance CBS Marketwatch BigCharts StockCharts.com Yahoo Lycos Investing Quicken Yahoo News Quote.com (Lycos) CNET news ZDNet Business Week Stock earnings, recommendationshttp://www.quotelinks.com/companies/iclr.htmlICON Plchttp://www.adrbny.com/dr_profile.jsp?cusip=45103T107ICON is a Clinical Research Organization providing a comprehensive range of clinical services in Phase I-IV clinical trials to the pharmaceutical and biotechnology industries.http://www.adrbny.com/dr_profile.jsp?cusip=45103T107ICON Plchttp://www.hoovers.com/icon/--ID__57184--/freeuk-co-factsheet.xhtmlBefore the newest drugs hit the market, they have to pass a long series of clinical trials to make sure they're safe and effective, and that's where ICON steps in. The firm provides drugmakers around the world with various services for their product candidates' clinical trials.http://www.hoovers.com/icon/--ID__57184--/freeuk-co-factsheet.xhtmlICON Plchttp://www.ddp-direkt.de/portal/details.php?id=7857DIE ÜBERSETZUNG INS DEUTSCHE ERFOLGT OHNE GEWÄHR. VERBINDLICH IST AUSSCHLIESSLICH DIE ORIGINALMELDUNG DES EMITTENTEN. (TRANSLATION INTO GERMAN LANGUAGE IS PROVIDED WITHOUT GUARANTEE. ONLY THE ORIGINAL MESSAGE OF THE ISSUER IS AUTHORITATIVE.) DUBLIN, Irland--(BUSINESS WIRE)-30.http://www.ddp-direkt.de/portal/details.php?id=7857ICON Plchttp://www.buyandhold.com/StockMgr?request=display.content&symbol=ICLR&ContentURL=%2Fcustom%2Fbuyandhold%2Dcom%2Fhtml%2Dnews%2Easp&symb=ICLRCopyright © 2007 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by ComStock, an Interactive Data Company and subject to the Terms of Use.http://www.buyandhold.com/StockMgr?request=display.content&symbol=ICLR&ContentURL=%2Fcustom%2Fbuyandhold%2Dcom%2Fhtml%2Dnews%2Easp&symb=ICLRICON Plchttp://www.iconclinical.com/index.asp?GetPress=TRUE&id=221&sid=4&ssid=0&sssid=0Dublin, Ireland, June 17, 2008 ICON plc (NASDAQ:ICLR) (ISIN: IE0001827041), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that its board of directors (the Board ) has recommended a Bonus Share Issue.http://www.iconclinical.com/index.asp?GetPress=TRUE&id=221&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconus.com/index.asp?GetPress=TRUE&id=146&sid=4&ssid=0&sssid=0The newly redesigned facility, located in South County Business Park, Leopardstown, increases the size of the laboratory by 30% and nearly doubles the size of the operational facilities supporting project management and global logistics services.http://www.iconus.com/index.asp?GetPress=TRUE&id=146&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconclinical.com/index.asp?GetPress=TRUE&id=194&sid=4&ssid=0&sssid=0Dublin, Ireland, November 22nd 2007 ICON plc (NASDAQ: ICLR), today announced that it will release its fiscal year 2008 financial guidance on Wednesday 19th December, before the market opens. The release will be available on the ICON Web site at www.iconplc.com . At 9:00 a.m.http://www.iconclinical.com/index.asp?GetPress=TRUE&id=194&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconclinical.com/index.asp?GetPress=TRUE&id=245&sid=4&ssid=0&sssid=0iconplc.com. A recording will also be available on the website for 90 days following the call. In addition, a calendar of company events, including upcoming conference presentations, is available on our website, under "Investors". This calendar will be updated regularly.http://www.iconclinical.com/index.asp?GetPress=TRUE&id=245&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconus.com/index.asp?gref=10,3&ccode=9&continent=2&getcountry=true&sid=14South County Business Park Leopardstown Dublin 18 Ireland tel: +353 1 291 2000 fax: +353 1 291 2700 email: info@iconirl.http://www.iconus.com/index.asp?gref=10,3&ccode=9&continent=2&getcountry=true&sid=14ICON Plchttp://www.iconus.com/index.asp?GetPress=TRUE&id=82&sid=4&ssid=0&sssid=0Dublin, Ireland, July 1, 2004 - ICON plc (NASDAQ: ICLR), a global clinical research organisation announced today that it had agreed to acquire a 70% interest in Beacon Bioscience, Inc., a leading specialist CRO in the Medical Imaging field.http://www.iconus.com/index.asp?GetPress=TRUE&id=82&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconus.com/index.asp?GetPress=TRUE&id=57&sid=4&ssid=0&sssid=0ICON is a global contract clinical research organisation, which has approximately 2,300 employees providing services to the pharmaceutical and biotech industries from 28 locations in 16 countries worldwide.http://www.iconus.com/index.asp?GetPress=TRUE&id=57&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconus.com/index.asp?GetPress=TRUE&id=55&sid=4&ssid=0&sssid=0ICON plc has filed an amended Form F3 Registration Statement for American Depositary Shares. For further information please go to SEC Filings page or click on the link below.http://www.iconus.com/index.asp?GetPress=TRUE&id=55&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconus.com/index.asp?GetPress=TRUE&id=49&sid=4&ssid=0&sssid=0ICON Files Registration Statement for American Depositary Shares Dublin, Ireland, January 31, 2003 - ICON plc (NASDAQ: ICLR) announced that it has filed a registration statement with the U.S.http://www.iconus.com/index.asp?GetPress=TRUE&id=49&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconus.com/index.asp?GetPress=TRUE&id=84&sid=4&ssid=0&sssid=0Dublin, Ireland, July 13, 2004 - ICON plc (NASDAQ: ICLR) announced that the company has scheduled Tuesday, July 27, 2004 at 6:00 EST [11:00 GMT / 12:00 CET] as the date for the release of its audited fourth quarter and full year fiscal 2004 results.http://www.iconus.com/index.asp?GetPress=TRUE&id=84&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconclinical.com/index.asp?GetPress=TRUE&id=218&sid=4&ssid=0&sssid=0(NASDAQ:ICLR) (ISIN: IE0001827041)Dublin, Ireland, May 28 2008 ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Professor Dermot Kelleher as a non-executive Director.http://www.iconclinical.com/index.asp?GetPress=TRUE&id=218&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconclinical.com/index.asp?GetPress=TRUE&id=180&sid=4&ssid=0&sssid=0The company was also rated as a leading CRO in the other key quality metrics assessed, namely overall quality of service and timeliness of database lock, or the point where databases are closed and ready for statistical analysis.http://www.iconclinical.com/index.asp?GetPress=TRUE&id=180&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconclinical.com/index.asp?GetPress=TRUE&id=158&sid=4&ssid=0&sssid=0Dr. Drudy holds a doctorate in Obstetrics and Gynaecology from Trinity College Dublin. She comes to ICON from the Department of Obstetrics and Gynaecology in the Royal College of Surgeons where she held the position of Research Scientist. "The addition of Dr.http://www.iconclinical.com/index.asp?GetPress=TRUE&id=158&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconclinical.com/index.asp?GetPress=TRUE&id=248&sid=4&ssid=0&sssid=0This accolade waas based on the combined success of ICON teams and individuals who won multiple awards and was presented by Professor Sir Trevor Jones.http://www.iconclinical.com/index.asp?GetPress=TRUE&id=248&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconus.com/index.asp?GetPress=TRUE&id=109&sid=4&ssid=0&sssid=0ICON Announces New Appointments Dublin, Ireland, Monday, August 30, 2005 ICON plc (NASDAQ: ICLR) today announced the appointment of Mr. Sean Leech, currently Chief Financial Officer, to the position of Executive Vice President Commercial and Organisational Development.http://www.iconus.com/index.asp?GetPress=TRUE&id=109&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconclinical.com/index.asp?GetPress=TRUE&id=246&sid=4&ssid=0&sssid=0ICON plc (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the acquisition of the remaining 30% shareholding of Beacon Bioscience Inc.http://www.iconclinical.com/index.asp?GetPress=TRUE&id=246&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconclinical.com/index.asp?GetPress=TRUE&id=185&sid=4&ssid=0&sssid=0ICON Named Favourite Contract Research Organisation by Pharmaceutical and Biotech firms Company receives highest ranking in independent industry survey. Dublin, Ireland, October 15th, 2007.http://www.iconclinical.com/index.asp?GetPress=TRUE&id=185&sid=4&ssid=0&sssid=0ICON Plchttp://www.iconus.com/index.asp?GetPress=TRUE&id=121&sid=4&ssid=0&sssid=0ADSs ) representing ordinary shares, 0.06 per share. The ADSs will be sold at various times and prices by ICON, certain selling shareholders identified in the registration statement or a combination of both.http://www.iconus.com/index.asp?GetPress=TRUE&id=121&sid=4&ssid=0&sssid=0ICON Plc